Home › Compare › GIVSY vs ARCC
GIVSY yields 3.25% · ARCC yields 10.65%● Live data
📍 GIVSY pulled ahead of the other in Year 2
Combined, GIVSY + ARCC cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GIVSY + ARCC for your $10,000?
Grupo de Inversiones Suramericana S.A. operates in the financial services, industry, and corporate venture sectors in Colombia and internationally. The company offers general and life insurance, as well as reinsurance; pension, saving, investment, and asset management services; investment funds; annuities; severance pay and complementary services; health plans; occupational hazards; and business, consumer, insurance, investment, offshore, private, and government banking, as well as treasury products. It also produces cement, concrete, and aggregates; provides processed foods, such as cold cuts, confectionery, chocolates, coffees, ice cream, pasta, and consumer foods; and offers power generation and distribution, real estate, road and airport concessions, and business support services. In addition, the company provides a technological solution to manage human talent information for companies; a digital marketplace for mortgage sector; a platform for engagement, marketing, sale, and administration of financial products; a health technology platform; tools to manage prevention and wellbeing programs; web and mobile platform based on artificial intelligence; platform for on-demand insurance; and risk capital fund for early-stage and growing technology companies. Further, it offers integrated information, technology, and knowledge solutions; and residential, functional conditioning, and rehabilitation services for the elderly. Additionally, the company provides data processing and leasing computer equipment, consultancy and advisory, promotion, and marketing services; management consultancy services; medical, paramedical, dental, and diagnostic aid services; risk management, telecommunication, and outsourcing services; and vehicle inspection, repair, purchase, and selling services, as well as acts as securities brokers; and purchases and sells securities. The company was incorporated in 1997 and is headquartered in Medellin, Colombia.
Full GIVSY Calculator →Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.
Full ARCC Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.